(Q67522837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

1 reference

1 reference

M. Keisu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358622

18 September 2022

E. Ekman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358622

18 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1358622

18 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

14 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

215-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

Adverse reactions during salazosulfapyridine (sulfasalazin) therapy in Denmark 1968-1987

14 September 2019

cites work

1 reference

12 December 2020

Drug-induced agranulocytosis

1 reference

12 December 2020

Leucopenia during sulphasalazine treatment for rheumatoid arthritis

1 reference

12 December 2020

Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study

1 reference

12 December 2020

The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.

1 reference

12 December 2020

Agranulocytosis associated with sulfasalazine.

1 reference

12 December 2020

Drug-induced neutropenia--a survey for Stockholm 1973-1978.

1 reference

12 December 2020

Sulfasalazine-induced agranulocytosis

1 reference

12 December 2020

Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years

1 reference

12 December 2020

Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control study

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02333012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1358622%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference